Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 28, 2017
Pharmacy Choice - News - Front Page Healthcare News - July 28, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/28/17 - "Antibody Drug Conjugates" in Patent Application Approval Process (USPTO 20170190736)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Miao, Zhenwei; Chen, Gang; Zhu, Tong; Khasanov, Alisher B.; Deng, Dylan; Zhang, Hong, filed on January 28, 2016, was made available online on July 13, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent ap
7/28/17 - "Apparatuses for Securing Components of a Drug Delivery System during Transport and Methods of Using Same" in Patent Application Approval Process...
"Apparatuses for Securing Components of a Drug Delivery System during Transport and Methods of Using Same" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors CABIRI, Oz; FILMAN, Reuven Y.; BAR-EL, Yossi, filed on March 17, 2017, was made available online on July 13, 2017
7/28/17 - "Contrast Agents for Magnetic Resonance Imaging" in Patent Application Approval Process (USPTO 20170189559)
By a News Reporter-Staff News Editor at Health& Medicine Week A patent application by the inventor Lascola, Christopher David, filed on March 17, 2017, was made available online on July 13, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. In the U.S., all nine FDA- approved MRI contrast agents are Gd-
7/28/17 - Abuse-Deterrent Opioid Development and Uptake Are Tied to Efficacy and Regulatory/Payer Policies, According to the Tufts Center for the Study of Drug...
By a News Reporter-Staff News Editor at Drug Week Although 10 new opioid products with abuse-deterrent formulations have received regulatory approval in the United States, lack of willingness by insurers to reimburse patients for their use is seen as a primary challenge limiting ADF uptake, according to the Tufts Center for the Study of Drug Deve
7/28/17 - Abzena and OBI Pharma Sign ThioBridge? Licence Agreement
By a News Reporter-Staff News Editor at Drug Week Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licensing agreement and a master services and clinical supply agreement with OBI Pharma, a Taiwanese biopharmaceutical company.
7/28/17 - AGRX At FDA Altar Again, AZN Falls As MYSTIC Fails, VBIV Delivers A Good Shot
Agile Therapeutics Inc.' s New Drug Application for Twirla, an investigational low-dose combined hormonal contraceptive patch, has been accepted for review by the FDA- with a decision date set for December 26, 2017. Twirla was turned down by the FDA in 2013. Amgen's supplemental Biologics License Application for Repatha to include data on reducing
7/28/17 - Bronchoscopes Market Report Key Players Analysis and Forecast 2024
Albany, NY 07/27/2017 Bronchoscopes belong to a type of endoscopy medical devices used to study the inner airways of the lungs. An instrument is inserted into the airways, usually through the nose or mouth, or occasionally through a tracheostomy. Bronchoscopes were first used reportedly in 1897 by Gustav Killian for an obstructive material re
7/28/17 - Claris Lifesciences sells injectables unit to Baxter [India Infoline News Service]
Claris Lifesciences has completed the planned sale of its generic injectables business to pharmaceutical major Baxter International Inc for USD 625 million. Claris Lifesciences has completed the planned sale of its generic injectables business to pharmaceutical major Baxter International Inc for USD 625 million. Claris Lifesciences will now...
7/28/17 - Colyer poised to become governor during key time in health care debate [The Wichita Eagle]
The path Colyer forges on health policy in Kansas would carry consequences for hundreds of thousands of Kansans and help determine his political fortunes. The transition would likely happen at a delicate time for health care in Kansas. At the same time, Congress is in the middle of an epic battle over health care and substantial changes to Medica
7/28/17 - Connecticut Hospital Association officials say program allowing for better coordinated care [New Haven Register, Conn.]
July 28 WALLINGFORD Officials with the Connecticut Hospital Association say a technological initiative, launched in May of last year, is working to to improve patient care. Jennifer Jackson, chief executive officer of the health care industry group, said in a statement that PatientPing allows providers to manage care "in a way that ensures pati
7/28/17 - Cosmo Half-Year Report 2017
Dublin, Ireland- 28 July 2017- Cosmo Pharmaceuticals N.V. reports half-year results for the period ended 30 June 2017. Expansion of organization to commercialize products in the US progressed with the addition of further personnel with strong sales and marketing experience LuMeBlue NDA submitted to the FDA on 21 July 2017 Zemcolo NDA under preparat
7/28/17 - Data from Office of Generic Drugs Advance Knowledge in Coumarins and Indandiones (Integrating In Vitro, Modeling, and In Vivo Approaches to...
Financial support for this research came from U.S. Food and Drug Administration. The news reporters obtained a quote from the research from the Office of Generic Drugs, "Sensitivity analyses indicated that warfarin pharmacokinetics was not sensitive to solubility, particle size, density, or dissolution rate in pH 4.5, but was affected by dissolutio
7/28/17 - Data on Psoriatic Arthritis Detailed by Researchers at St. Vincent's University Hospital (Abatacept reduces synovial regulatory T-cell expression in...
Data on Psoriatic Arthritis Detailed by Researchers at St. Vincent's University Hospital. According to news reporting from Dublin, Ireland, by NewsRx journalists, research stated, "The aim was to study changes in immunohistochemical expression markers of synovial and skin inflammation, clinical outcomes and magnetic resonance imaging scores with...
7/28/17 - Empty Capsules Market : Industry Analysis, Opportunity Assessment and Forecast Up to 2023
Albany, NY 07/27/2017 The empty capsules market is a key part of the global pharmaceutical industry and is likely to exhibit steady growth in the coming years due to the rapid proliferation of the pharmaceuticals sector in developing regions. However, growing opposition to animal-derived gelatin in economically crucial markets such as India,
7/28/17 - Establishment of Quality Government Guidelines Helps in Growing Hospital Infectious Disease Testing Market Up to 2024
Albany, NY 07/27/2017 Hospital infectious disease testing is a procedure to identify hospital acquired/related infections. Hospital infections are among the most prominent challenges faced by health care delivery systems across the globe. Hospital infectious diseases are considered a significant cause of death globally.
7/28/17 - Federal Register Table of Contents
Table of Contents Office of the Federal Register Agency for Healthcare Research and Quality NOTICES Agency Information Collection Activities; Proposals, Submissions, and Approvals, 35205-35212 Agriculture Department SeeAnimal and Plant Health Inspection Service SeeFood and Nutrition Service Alcohol, Tobacco, Firearms, and Explosives Bureau NOTICES.
7/28/17 - Findings on Biological Regulators and Homeostatic Agents Reported by A. Baj et al (Bidirectional flux of fluids and microbiota at implant-abutment...
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Biological Regulators and Homeostatic Agents have been presented. According to news reporting originating in Milan, Italy, by NewsRx journalists, research stated, "The purpose of the present microbiological study was to evaluate bacterial leakage at implant-ab
7/28/17 - GOP pushes new Obamacare repeal, hoping it never becomes law [Philly.com]
July 27 WASHINGTON On the brink of defeat, Senate Majority Leader Mitch McConnell has kept alive the GOP promise of dismantling the Affordable Care Act by essentially telling fellow Republicans: it's this or nothing. And after seven years of promises to end Obamacare, most Republicans don't want' nothing.'. To get there, the Senate has to pass
7/28/17 - Hospitals that spend more initially yield better outcomes
By a News Reporter-Staff News Editor at Insurance Weekly News Hospitals that spend more on initial care following patient emergencies have better outcomes than hospitals that spend less at first and rely more on additional forms of long-term care, according to a new study co-authored by MIT economists. The co-authors are Doyle; John A. Graves, an
7/28/17 - HUYA Bioscience International Establishes Strategic Partnership with Suzhou BioTOP
By a News Reporter-Staff News Editor at Drug Week HUYA Bioscience International, the leader in accelerating global development of China's pharmaceutical innovations, announced a strategic collaboration agreement with Suzhou BioTOP Technical Service Co., Ltd.. The company accelerates the development and value creation for China- sourced novel...
7/28/17 - Janssen Enters Collaboration With Bavarian Nordic to Develop Vaccines Against Hepatitis B Virus, HIV-1
Johnson and Johnson issued the following news release:. Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson& Johnson, announced today that it has entered into a worldwide exclusive license and collaboration agreement with Bavarian Nordic to leverage their MVA-BN technology with Janssen's own AdVac and DNA-based...
7/28/17 - Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Cardiovascular Status Indicator
FOR FURTHER INFORMATION CONTACT: Nathalie Yarkony, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1254, Silver Spring, MD 20993-0002, 301-796-1235, nathalie.yarkony@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In accordance with section 513 of the Federal Food, Drug, and Cosmetic Act, de
7/28/17 - Medical Devices; Gastroenterology-Urology Devices; Classification of the Oral Removable Palatal Space Occupying Device for Weight Management and/or...
SUMMARY: The Food and Drug Administration is classifying the oral removable palatal space occupying device for weight management and/or weight loss into class II. FOR FURTHER INFORMATION CONTACT: Mark Antonino, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. SUPPLEMENTARY INFORMATION
7/28/17 - Medical Devices; Neurological Devices; Classification of Cranial Motion Measurement Device
FOR FURTHER INFORMATION CONTACT: Jay Gupta, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 2630, Silver Spring, MD 20993-0002, 301-796-2795, jay.gupta@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In accordance with section 513 of the Federal Food, Drug, and Cosmetic Act, devices that wer
7/28/17 - Medical Devices; Obstetrical and Gynecological Devices; Classification of the Closed Loop Hysteroscopic Insufflator With Cutter-Coagulator
FOR FURTHER INFORMATION CONTACT: Veronica Price, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. SUPPLEMENTARY INFORMATION: In accordance with section 513 of the Federal Food, Drug, and Cosmetic Act, devices that were not in commercial distribution before May 28, 1976, generally refe
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415